Rebif Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

Comparison of Rebif Compared to Tecifdera on Six-month Outcomes in Patients With Relapsing-remitting MS
Condition:   Multiple SclerosisInterventions:   Drug: Rebif (IFN β-1a subcutaneous three times per week);   Drug: Tecifdera (dimethyl fumarate)Sponsors:   Brigham and Women's Hospital;   EMD SeronoNot yet recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 14, 2015 Category: Research Source Type: clinical trials

Study to Evaluate the Pharmacokinetic Profiles of BIIB017 (Peginterferon Beta-1a) and Rebif® (Interferon Beta-1a) in Healthy Volunteers
Condition:   Multiple SclerosisInterventions:   Drug: peginterferon beta-1a;   Drug: RebifSponsor:   Biogen IdecNot yet recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2014 Category: Research Source Type: clinical trials